ReveraGen BioPharma (United States)
Open Access statistics for ReveraGen BioPharma (United States), United States, covering academic research published from 2012 to 2025.
Open Access statistics for ReveraGen BioPharma (United States), United States, covering academic research published from 2012 to 2025. Read More.
Open Access Percentage
79%
Total
Publications
75
Total Open
Publications
59
Total
Citations
1.8K
Open Access
Percentage
79%
Total
Publications
75
Total Open
Publications
59
Total
Citations
1.8K
Breakdown
Publisher Open
7%
Both
56%
Other Platform Open
15%
Closed
22%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 52%
24
Hybrid 22%
10
No Guarantees 26%
12
Other Platform Open
Domain 90%
47
Institution 40%
21
Preprint 4%
2
Other Internet 2%
1
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 47 |
doaj.org OAI-PMH Repository | Institution | 12 |
Europe PMC | Domain | 3 |
California Digital Library | Institution | 3 |
University of Padua | Institution | 2 |
The University of Melbourne | Institution | 2 |
medRxiv | Preprint | 2 |
University of Edinburgh | Institution | 1 |
University of Copenhagen | Institution | 1 |
unil.ch OAI-PMH Repository | Institution | 1 |